Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 15.26M | 15.63M | 16.38M | 16.64M | 16.90M |
| Total Depreciation and Amortization | 3.16M | 4.20M | 5.29M | 6.37M | 7.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -558.00K | -654.00K | -651.00K | -489.00K | -65.00K |
| Change in Net Operating Assets | -630.00K | -686.00K | -371.00K | -233.00K | -1.29M |
| Cash from Operations | 17.23M | 18.49M | 20.64M | 22.28M | 22.63M |
| Capital Expenditure | -311.00K | -408.00K | -618.00K | -639.00K | -587.00K |
| Sale of Property, Plant, and Equipment | 27.00K | 27.00K | 27.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00K | -5.00K | -- | -- | 0.00 |
| Cash from Investing | -289.00K | -386.00K | -591.00K | -639.00K | -587.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 390.00K | 426.00K | 192.00K | 117.00K | 248.00K |
| Repurchase of Common Stock | -13.26M | -9.39M | -2.99M | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.29M | -4.31M | -4.30M | -4.28M | -4.26M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.16M | -13.28M | -7.10M | -4.17M | -4.01M |
| Foreign Exchange rate Adjustments | 468.00K | -226.00K | -56.00K | 339.00K | 670.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 243.00K | 4.60M | 12.90M | 17.82M | 18.70M |
